期刊文献+

120W与160W等离子电切治疗良性前列腺增生症的临床研究 被引量:2

暂未订购
导出
摘要 良性前列腺增生症是泌尿系统中最为常见的疾病之一.为老年男性高发病,随着生活水平的不断提高.其发病率亦呈逐年上升趋势,且发表年龄提前。其治疗方式多以口服药物(α1受体阻滞剂)或手术治疗为主,手术方法包含开放式与腔内微创手术,其腔内微创手术多以经尿道等离子电切术为主,已在临床运用多年,技术相对成熟,
出处 《中国药物与临床》 CAS 2014年第3期384-386,共3页 Chinese Remedies & Clinics
  • 相关文献

参考文献8

二级参考文献61

  • 1卢道妃,杨柳平,谭勇福.经尿道前列腺电切术的临床应用及护理[J].实用医技杂志,2008,15(23):3106-3108. 被引量:5
  • 2吴伟江,王行环,王怀鹏,邹伟波,梁晓宇,蔡志高,钟巍巍,邹永锋,袁道彰.经尿道等离子体双极电切与经尿道普通电切对前列腺增生症的疗效比较[J].中华医学杂志,2005,85(47):3365-3367. 被引量:102
  • 3Cazzola M, Malcovati L. Myelodysplastic syndromes-Coping with ineffective hematopoiesis [J]. NEngl JMed 2005; 352:536-8.
  • 4Greenberg P, Cox C, LeBeau MM, et al. International scoring system for evaluating prognosis in myelodysplastic syndromes [J]. Blood 1997; 89:2079-88.
  • 5Vardiman JW, Harris NL, Brunning RD. The World Health Organization (WHO) classification of the myeloid neoplasms [J]. Blood 2002; 100: 2292-302.
  • 6Howe RB, Porwit-MacDonald A, Wanat R, et al. The WHO classification of MDS does make a difference [J]. Blood 2004; 103:3265-70.
  • 7Breccia M, Carmosino I, Biondo F, et al. Usefulness and prognostic impact on survival of WHO reclassification in FAB low risk myelodyplastic syndromes [J]. Leuk Res 2006; 30:178-82.
  • 8Malcovati L, Porta MG, Pascutto C, et al. Prognostic factors and life expectancy in myelodysplastic syndromes classified according to WHO criteria: a basis for clinical decision making [J]. J Clin Oncol 2005; 23:7594-603.
  • 9Malcovati L, Germing U, Kuendgen A ,et al.Time-dependent prognostic scoring system for predicting survival and leukemic evolution in myelodysplastic syndromes [J]. J Clin Oncol 2007; 25-3503-10.
  • 10Muller-Berndorff H, Haas PS, Kunzmann R, et al. Comparison of five prognostic scoring systems, the French-American-British (FAB) and World Health Organization (WHO) classifications in patients with myelodysplastic syndromes: Results of a single-center analysis [J]. Ann Hematol 2006;85:502-13.

共引文献44

同被引文献24

  • 1陈向东,唐涌志,丁满棠,肖军,杨鲲.PKEP术中保持膀胱颈完整性的意义[J].中国男科学杂志,2006,20(6):25-27. 被引量:8
  • 2Pu XY, Wang XH, Wang HP, et al. Erectile dysfunction after PlasmaKinetic vaporization of the prostate: Incidence and risk factors[J]. J Endourol, 2006, 20(9): 693-7.
  • 3Taher A. Erectile dysfunction after transurethral resection of the prostate: incidence and risk factors [J]. World J Urol, 2004, 22(6): 457-60.
  • 4Kapasi FM, Chandrasekar P, Virdi J. A prospctive randomised study between transurethral vaporisation using plasmakinetic energy and transurethral resection of the prostate[J]. J Urol, 2003, 169(4suppl): 391-2.
  • 5Rothenberger K, Pensel J, Hofstetter A, et al. Controlled bipolar high-frequency coagulation for transurethral application: a new method for the destruction of urinary bladder tumors J]. Urol Int, 1983, 38(5): 257-62.
  • 6Kramolowsky EV, Tucker RD. Use of 5F bipolar electrosurgic probe in endoscopic urological procedures[J]. J Urol, 1990, 14(2): 275-7.
  • 7Ronzoni G, De Vecchis M. Preservation of anterograde ejaculation after transurethral resection of both the prostate and bladder neck [J]. Br J Urol, 1998, 81(6): 830-3.
  • 8Stolzenburg JU, Rabenalt R, Do M, et al. Intrafascial nerve-sparing endoscopic extraperitoneal radical prostatectomy [J]. Eur Urol, 2008, 53: 931-40.
  • 9Muntener M, Aellig S, Kuettel R, et al. Sexual function after transurethral resection of the prostate (TURP): Results of an Independent prospective multicentre assessment of outcome[J3. Eur Urol, 200% 52(2): 510-6.
  • 10徐战平,王行环,王怀鹏,郑祥光,刘久敏,陈浩阳,罗耀雄.经尿道等离子双极电切治疗高危良性前列腺增生300例[J].广东医学,2008,29(10):1613-1615. 被引量:10

引证文献2

二级引证文献19

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部